FOXO1 and sensorineural hearing loss disorder: These findings confirm the role of the FOXO1‐NCOA4 axis in regulating ferritinophagy and ferroptosis in response to cisplatin‐induced SGN damage, highlighting promising therapeutic targets for mitigating sensorineural hearing loss.